Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 5/20 | 0.39 |
| ▸ | NPC1 | O15118 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MPI | P34949 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9583273 | 0.78 | ALDH1A1 (0.52) | ALDH1A1TSHRMAPTL3MBTL1LMNA | |
| SCHEMBL12438887 | 0.78 | ALDH1A1 (0.52) | ALDH1A1TSHRMAPTL3MBTL1LMNA | |
| SCHEMBL13954093 | 0.78 | ALDH1A1 (0.52) | ALDH1A1TSHRMAPTL3MBTL1LMNA | |
| SCHEMBL406151 | 0.76 | FGF23 (0.53) | ALDH1A1TSHRMAPTL3MBTL1LMNA | |
| SCHEMBL29367737 | 0.76 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPTL3MBTL1LMNA | |
| SCHEMBL16317365 | 0.76 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPTL3MBTL1LMNA | |
| SCHEMBL16587281 | 0.76 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPTL3MBTL1LMNA | |
| SCHEMBL10924404 | 0.76 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPTL3MBTL1LMNA | |
| SCHEMBL2160910 | 0.76 | FGF23 (0.53) | ALDH1A1TSHRMAPTL3MBTL1LMNA | |
| SCHEMBL1396871 | 0.76 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPTL3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3932926-B1 | LIGHT EMITTING ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2023-11-08 | — | — | EP | disclosed |
| US-11639330-B2 | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | SHOWA DENKO K.K. (JP) | 2023-05-02 | — | — | US | disclosed |
| EP-3428989-B1 | LIGHT-EMITTING ELEMENT | SUMITOMO CHEMICAL CO (JP) | 2021-04-21 | — | — | EP | disclosed |
| US-20190210975-A1 | CYCLIC COMPOUND ACTING AS PDE4 INHIBITOR | MEDSHINE DISCOVERY INC. (CN) | 2019-07-11 | — | — | US | disclosed |
| EP-3428989-A1 | LIGHT-EMITTING ELEMENT | Sumitomo Chemical Company Limited (JP) | 2019-01-16 | — | — | EP | disclosed |
| US-20180098994-A9 | PROCESS FOR PREPARATION OF OPTICALLY PURE AND OPTIONALLY SUBSTITUTED 2-(1-HYDROXY-ALKYL)-CHROMEN-4-ONE DERIVATIVES AND THEIR USE IN PREPARING PHARMACEUTICALS | RHIZEN PHARMACEUTICALS AG (CH) | 2018-04-12 | — | — | US | disclosed |
| US-20170266196-A1 | PROCESS FOR PREPARATION OF OPTICALLY PURE AND OPTIONALLY SUBSTITUTED 2-(1-HYDROXY-ALKYL)-CHROMEN-4-ONE DERIVATIVES AND THEIR USE IN PREPARING PHARMACEUTICALS | RHIZEN PHARMACEUTICALS SA (CH) | 2017-09-21 | — | — | US | disclosed |
| US-20170114040-A1 | SUBSTITUTED TRIAZOLE DERIVATIVES AS OXYTOCIN ANTAGONISTS | PFIZER LIMITED (GB) | 2017-04-27 | — | — | US | disclosed |
| US-9309216-B2 | Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals | RHIZEN PHARMACEUTICALS SA (CH) | 2016-04-12 | — | — | US | disclosed |
| US-9228949-B2 | Aggregation-induced emission luminogens for metal ion detection | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2016-01-05 | — | — | US | disclosed |
| US-20150087699-A1 | NOVEL PROCESS FOR PREPARATION OF OPTICALLY PURE AND OPTIONALLY SUBSTITUTED 2-(1-HYDROXY-ALKYL)-CHROMEN-4-ONE DERIVATIVES AND THEIR USE IN PREPARING PHARMACEUTICALS | RHIZEN PHARMACEUTICALS AG (CH) | 2015-03-26 | — | — | US | disclosed |
| US-8734963-B2 | Complex salts | BASF SE (DE) | 2014-05-27 | — | — | US | disclosed |
| EP-2128168-B1 | METAL COMPLEX, POLYMER COMPOUND AND DEVICE CONTAINING THOSE | SUMITOMO CHEMICAL CO (JP) | 2013-11-06 | — | — | EP | disclosed |
| US-20130059392-A1 | AGGREGATION-INDUCED EMISSION LUMINOGENS FOR METAL ION DETECTION | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2013-03-07 | — | — | US | disclosed |
| US-8188123-B2 | (Pyrrolidin-2-yl)phenyl derivatives | MERCK SHARP & DOHME B.V. (NL) | 2012-05-29 | — | — | US | disclosed |
| US-20110177630-A1 | COMPLEX SALTS | BASF SE (DE) | 2011-07-21 | — | — | US | disclosed |
| US-20100113493-A1 | (PYRROLIDIN-2-YL)PHENYL DERIVATIVES | N.V. ORGANON | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11639330-B2 | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | AFF1, PHOSPHO1, CHRM1 | ALDH1A1 3194/4885TSHR 521/4885MAPT 2330/4885 |
| US-20150087699-A1 | NOVEL PROCESS FOR PREPARATION OF OPTICALLY PURE AND OPTIONALLY SUBSTITUTED 2-(1-HYDROXY-ALKYL)-CHROMEN-4-ONE DERIVATIVES AND THEIR USE IN PREPARING PHARMACEUTICALS | CYP4B1, ADH1A, CYP1A2 | ALDH1A1 86/4885TSHR 1767/4885MAPT 3286/4885 |
| US-20100113493-A1 | (PYRROLIDIN-2-YL)PHENYL DERIVATIVES | CNR1, CNR2, TRPV1 | ALDH1A1 1934/4885TSHR 1070/4885MAPT 3040/4885 |
| US-20170114040-A1 | SUBSTITUTED TRIAZOLE DERIVATIVES AS OXYTOCIN ANTAGONISTS | OXTR, AVPR1B, GNRHR | ALDH1A1 3751/4885TSHR 247/4885MAPT 1696/4885 |
| US-20130059392-A1 | AGGREGATION-INDUCED EMISSION LUMINOGENS FOR METAL ION DETECTION | PARN, IK, PARG | ALDH1A1 2125/4885TSHR 1524/4885MAPT 1279/4885 |
| US-20110177630-A1 | COMPLEX SALTS | NCLN, AP3M1, AP2M1 | ALDH1A1 3608/4885TSHR 3505/4885MAPT 2718/4885 |
| US-20180098994-A9 | PROCESS FOR PREPARATION OF OPTICALLY PURE AND OPTIONALLY SUBSTITUTED 2-(1-HYDROXY-ALKYL)-CHROMEN-4-ONE DERIVATIVES AND THEIR USE IN PREPARING PHARMACEUTICALS | CYP4B1, ADH1A, CYP1A2 | ALDH1A1 76/4885TSHR 1769/4885MAPT 3351/4885 |
| US-20190210975-A1 | CYCLIC COMPOUND ACTING AS PDE4 INHIBITOR | PDE4A, PDE4B, PDE5A | ALDH1A1 608/4885TSHR 3186/4885MAPT 2971/4885 |
| US-20170266196-A1 | PROCESS FOR PREPARATION OF OPTICALLY PURE AND OPTIONALLY SUBSTITUTED 2-(1-HYDROXY-ALKYL)-CHROMEN-4-ONE DERIVATIVES AND THEIR USE IN PREPARING PHARMACEUTICALS | CYP4B1, ADH1A, CYP1A2 | ALDH1A1 76/4885TSHR 1769/4885MAPT 3351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.